Read this before anything else on this site.
MyRxWallet DAO, LLC is a wholly owned subsidiary of MyRxWallet North America Corporation. MyRxWallet DAO, LLC is a distinct legal entity from MyRxWallet DAO, Inc., a separately incorporated affiliate also controlled by MyRxWallet North America Corporation.
Information on this website concerning planned technology, features, functionality, tokens, governance mechanisms, or capabilities may constitute forward-looking information. Certain systems described on this website — including the EHR core platform, FHIR APIs, patient/provider portals, Hyperledger infrastructure, and smart-contract layer — are technically operational in production environments, but the company remains pre-commercial and has not demonstrated the platform at commercial scale with external users.
Other systems described on this website — including the AI/ML clinical and bio-genomics engine, NFT-based digital identity, MyRxToken, hyperscale infrastructure, and biobank infrastructure — are planned and have not yet been built.
MyRxToken is described as a planned closed-loop healthcare rewards unit. It is not intended to function as, or be marketed as, a cryptocurrency or digital asset, and is not intended to be listed on any digital-asset exchange. The company has not obtained a no-action letter or formal SEC determination regarding its regulatory treatment.
Completion of technical testing, including the ONC Inferno v8.0.0 test suite, should not be interpreted as final ONC certification. Certification activities, including engagement with an ONC-Authorized Certification Body, remain separate and subject to completion.
References to the October 2025 acquisition of MyRxWallet DAO, LLC describe an all-equity transaction with a contractual value of $500 million, agreed by the parties and the board. No formal third-party appraisal supported this valuation.
References to planned revenue sources, including technology licensing, DAO transaction fees, and governance services, describe a planned commercial model. MyRxWallet North America Corporation remains pre-revenue as of the financial statements referenced in its SEC filing.
For securities-related information concerning MyRxWallet North America Corporation, readers should refer to filings made with the U.S. Securities and Exchange Commission.